Haoxi Health Technology Ltd

Snapshot

Haoxi is a tiny Chinese digital-marketing micro-cap with FY 2025 revenue of $32.8M, down 32.4% from a year earlier, and a razor-thin 2.8% gross margin. It lost money operationally (-$2.0M operating income) and burned $3.4M in free cash flow, against just $6.8M in cash.

What's Happening Right Now

• Wed 12th Aug '26 · Reverse split: Haoxi effected a second reverse share split, 1-for-20, effective August 14, 2026, cutting Class A shares from about 11.9 million to roughly 595,000, intended to meet Nasdaq's minimum bid price rule.
• Mon 27th Jul '26 · Short interest: Short interest jumped 810.7% in July 2026 to about 545,000 shares, roughly 7.4% of the float at the time.
• Tue 14th Jul '26 · Partnership: On July 14, 2026, Haoxi signed a strategic cooperation framework with NOVA MEDIA to build an AI digital marketing system using generative AI and digital humans; no financial terms were disclosed.
• Tue 14th Jul '26 · Offering: Haoxi closed a registered direct offering on July 14, 2026, raising $4M gross by selling shares and pre-funded warrants through Univest Securities, with proceeds earmarked for working capital and possible acquisitions.
• Mon 13th Jul '26 · Going concern: A July 13, 2026 prospectus disclosed an auditor's report expressing substantial doubt about the company's ability to continue as a going concern, alongside a $4M offering priced at $0.40/share following a 128-for-1 reverse split.